Richard J. Hawkins
Independent Chairman of the BoardMr. Richard J. Hawkins, also known as Rick, is Operating Partner of Havencrest Healthcare Partners. He was the Founder of Lumos Pharma, Inc. and had been its Chairman of the Board since March 26, 2020, its Chief Executive Officer since January 2011 and served as its President since January 2011 until July 2021. He is Founder of Aether Therapeutics Inc. and serves as its Chairman since 2025. He had been Chief Executive Officer and Director of NewLink Genetics Corporation since March 18, 2020. Mr. Hawkins is Operating Partner at Havencrest Capital Management, LLC. Mr. Hawkins served as a Business Advisor at Spindletop Capital. He served as a Member of Executive Council and Venture Partner at the firm. He founded LabNow, Inc. in September 2003 and served as its Chief Executive Officer, Chairman until October 2009 and President. From 1981 to 2000, Mr. Hawkins Founded Pharmaco in 1981 and served as its President and Chief Executive Officer from 1981 to 2000. From 2000 to 2010, Mr. Hawkins, founded and advised numerous pharmaceutical companies. After selling Pharmaco, Mr. Hawkins was the Founder of id2 and served as its Chairman and Chief Executive Officer. He co-founded Covance Biotechnology Services, Inc. In 1992, he founded Sensus Drug Development Corporation (SDDC). He served as Advisor and Mentor of Sensus Drug Development Corporation. He co-founded Corning Biopro in 1994, where he served on its Board until Corning BioPro’s sale to Akzo-Nobel, N.V., a publicly held producer of paints, coatings and specialty chemicals, in 2000. He has been the Independent Chairman of Board at Cerenome, Inc. (formerly known as Plus Therapeutics, Inc.) (Formerly, Cytori Therapeutics, Inc.), since January 25, 2018. He serves as the Chairman of the Board at ENTvantage Diagnostics, Inc. Mr. Hawkins served as Chairman and Director of Synarc, Inc. He served as the Chairman of LoopOne, Inc. He serves as Director at and Savara Inc. He has been an Independent Director of Cerenome, Inc. (formerly known as Plus Therapeutics, Inc.), since December 20, 2007. He has been an Independent Director of Savara, Inc. since December 20, 2007. Mr. Hawkins is a Member of the National Ernst & Young Entrepreneur of the Year Hall of Fame. He served as the Chairman of Sensus Drug Development Corporation (SDDC) until 2000. He has been Director of Lumos Pharma, Inc since January 2011. He served as Member of the Scientific Advisory Board and Director of LabNow, Inc. He served as an Independent Director at SciClone Pharmaceuticals, Inc. from October 2004 to October 2017. He served as a Director of Covance Biotechnology Services, Inc. He has also served on the Presidential Advisory Committee for the Center for Nano and Molecular Science and Technology at the University of Texas in Austin. He is a highly experienced executive in the pharmaceutical industry. In 2006, he received Ohio University’s Distinguished Business Achievement Award and was named one of the top 10 Life Sciences CEO’s in Texas by the Texas Healthcare & Bioscience Institute. He was inducted into the Hall of Honors for the School of Natural Sciences at the University of Texas in Austin. Mr. Hawkins graduated cum laude with a B.S. in Biology from Ohio University in 1974.
Positions
- Company NameCerenome, Inc.Stock CodeCNSYPositionIndependent Chairman of the BoardColleagues
- MHMarc H. HedrickPresident, CEO & Director
- RJRichard J. HawkinsIndependent Chairman of the Board
- AJAndrew J. SimsVP & CFO
- EJEric J. DanielsChief Development Officer & COO
- RHRuss HavranekExecutive Vice President of Commercial and Corporate Strategy
- RARonald A. AndrewsChief Business Officer & Director
- AVAn van Es-JohanssonIndependent Director
- HCHoward ClowesIndependent Director
- Company NameSavara Inc.Stock CodeSVRAPositionIndependent Director
